Updates
** New Zealand's Fisher & Paykel Healthcare FPH.NZ falls 1.7% to NZ$36.13, loses 0.8% for the week
** Stock set for weakest week since April 5
** Jefferies downgrades to "hold" from "buy", keeps PT unchanged at NZ$39.40
** Says it's interested in knowing impact of U.S. tariffs to date, when co reports FY25 results on May 28; will closely watch co's mitigation strategies
** Notes, "We understand the primary impact on FPH imports is currently a 10% tariff on New Zealand products"
** Stock rated "hold" on avg; median PT is NZ$35.81, per data compiled by LSEG
** YTD, FPH falls ~6%
(Reporting by Roshan Thomas and Nikita Maria Jino in Bengaluru)
((Roshan.Thomas@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.